Mayne Pharma Group Balance Sheet

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Cash & Equivalents	67.35	59.84	110.07	92.62	96.67	97.98
Short-Term Investments	0.1	40.56	39.21	127.53	-	-
Trading Asset Securities	-	-	-	-	1.33	-
Cash & Short-Term Investments	67.45	100.4	149.28	220.14	98.01	97.98
Cash Growth	-46.00%	-32.74%	-32.19%	124.62%	0.03%	-28.89%
Accounts Receivable	173.94	164.62	176.47	177.4	259.72	175.83
Other Receivables	18.65	17.28	31.21	32.12	23.3	17.51
Receivables	192.59	181.9	207.68	209.52	283.02	193.34
Inventory	47.5	50.56	74.63	82.7	108.91	102.51
Prepaid Expenses	29.25	16.37	19.2	13.1	11.57	8.85
Restricted Cash	-	2.37	2.32	9.1	0.41	0.37
Other Current Assets	4.34	1.19	7.49	19.08	9.71	13.48
Total Current Assets	341.13	352.79	460.59	553.63	511.62	416.53
Property, Plant & Equipment	57.11	58.87	53.33	51.48	225.86	221.6
Goodwill	-	-	-	-	22.13	59.54
Other Intangible Assets	499.83	542.11	567.86	615.23	396.32	1,068
Long-Term Deferred Tax Assets	24.13	41.76	45.34	22.66	118.49	172.21
Long-Term Deferred Charges	3.29	3.67	0.72	2.04	9.07	-491.28
Other Long-Term Assets	15.07	15.41	15.34	2.32	4.45	16.7
Total Assets	940.55	1,015	1,143	1,247	1,288	1,463
Accounts Payable	23.31	30.25	20.87	32.03	63.57	42.36
Accrued Expenses	163.96	140.41	179.85	195.87	113.19	63.78
Short-Term Debt	-	-	-	10.81	405.37	51.16
Current Portion of Long-Term Debt	37.05	35.15	31.64	-	-	1.08
Current Portion of Leases	3.26	3.46	3.82	3.62	2.63	2.89
Current Income Taxes Payable	-	-	-	-	1.22	-
Other Current Liabilities	29.81	51.73	109.39	68.64	43.33	61.26
Total Current Liabilities	257.38	261.01	345.58	310.96	629.31	222.53
Long-Term Debt	-	-	-	28.48	-	285.8
Long-Term Leases	2.15	2.66	3.36	4.6	5.67	6.97
Pension & Post-Retirement Benefits	0.48	0.46	0.33	0.3	0.28	0.65
Long-Term Deferred Tax Liabilities	6.15	8.8	7.35	7.8	6.03	13.46
Other Long-Term Liabilities	321.68	371.4	332.37	260.86	108.4	162.19
Total Liabilities	587.84	644.32	688.99	612.99	749.7	691.61
Common Stock	1,230	1,226	1,224	1,234	1,239	1,239
Retained Earnings	-1,056	-1,041	-944	-769.77	-840.35	-559.06
Comprehensive Income & Other	178.86	185.29	173.97	170.44	147.7	88.88
Total Common Equity	352.71	370.28	454.19	634.36	545.88	768.36
Minority Interest	-	-	-	-	-7.65	3.22
Shareholders' Equity	352.71	370.28	454.19	634.36	538.23	771.58
Total Liabilities & Equity	940.55	1,015	1,143	1,247	1,288	1,463
Total Debt	42.47	41.27	38.82	47.51	413.67	347.9
Net Cash (Debt)	24.98	59.13	110.46	172.64	-315.66	-249.92
Net Cash Growth	-70.63%	-46.47%	-36.02%	-	-	-
Net Cash Per Share	0.31	0.75	1.39	2.10	-3.84	-3.18
Filing Date Shares Outstanding	81.25	81.25	81.25	83.42	88.24	88.24
Total Common Shares Outstanding	81.25	81.25	81.25	83.42	88.24	88.24
Working Capital	83.74	91.78	115.01	242.67	-117.69	194
Book Value Per Share	4.34	4.56	5.59	7.60	6.19	8.71
Tangible Book Value	-147.12	-171.82	-113.67	19.14	127.44	-359.08
Tangible Book Value Per Share	-1.81	-2.11	-1.40	0.23	1.44	-4.07
Land	2.98	2.98	2.98	2.98	8.1	9.17
Buildings	19.92	19.92	19.92	19.92	128.95	112.53
Machinery	67.72	63.69	60.62	65.59	184.83	166.88
Construction In Progress	11.15	14.04	6.63	-0.01	11.18	15.24

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.